Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leucovorin Calcium Dose-Response in Autism Spectrum Disorder (Children ≤6 Years)
ChiCTR2600122145Phase 4Not yet recruiting
- Sponsor
- Shenzhen Luohu Maternal and Child Health Care Hospital
- Start
- Apr 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of folinic acid in Autism Spectrum Disorder (ASD) (4 arms), sponsored by Shenzhen Luohu Maternal and Child Health Care Hospital. Primary endpoints: Wechsler Preschool and Primary Scale of Intelligence (WPPSI-IV) at week 0, Developmental Scale for Children's Psychological Behavior (Second Edition) at week 0 and 5 more. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
folinic acid
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on ChiCTR2600122145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122145.